Skip to content

Evaluating the efficacy and safety of L-Arabic syrup in bowel preparation: a multicenter prospective randomized controlled trial

Evaluating the efficacy and safety of L-Arabic syrup in bowel preparation: a multicenter prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043452
Enrollment
Unknown
Registered
2021-02-18
Start date
2022-06-20
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Interventions

experiment group:L-Arabinose syrup
control group:PEG-ELP (IV)

Sponsors

The Seventh Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Outpatients aged 18–75 years undergoing a colonoscopy who had provided written informed consent, and without blood-activating drugs for 5-7 days before examination were eligible for participation in the study.

Exclusion criteria

Exclusion criteria: 1. Bowel preparation within 14 days; 2. previous significant abdominal surgeries; 3. dysphagia, compromised swallowing reflex, or mental status; 4. significant gastroparesis or gastric outlet obstruction or ileus; 5. known or suspected bowel obstruction or perforation; 6. severe chronic renal failure (creatinine clearance170 mm Hg, diastolic blood pressure>100 mm Hg); 9. suffering from cardiovascular and cerebrovascular diseases or previous history of cardiovascular and cerebrovascular accidents; 10. severe constipation; 11. severe acute inflammatory bowel disease or toxic colitis or megacolon; 12. dehydration, disturbance of electrolytes, or hemodynamically unstable; 13. pregnancy or lactation; 14. allergy to the preparation components; 15. use of tricyclic antidepressants or narcotics.

Design outcomes

Primary

MeasureTime frame
the rate of adequate bowel preparation based on BBPS scale;

Secondary

MeasureTime frame
comfort and tolerance evaluation of the two groups of subjects;willingness to repeat bowel preparation;cleansing quality for each segment of the colon (right, transverse, and left colon segments);caecal intubation rate;adenoma detection rate;caecal intubation time;flushing water consumption during operation;electrolyte disturbance;changes in liver and kidney function;the incidence of adverse reactions during bowel preparation;

Countries

China

Contacts

Public ContactXin Wang

The Seventh Medical Center of Chinese PLA General Hospital

chan805126@126.com+86 18801040022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026